By Accountable Care Journal-
The NHS is increasing deployments of AI cyber defence, developed by cybersecurity firm, Darktrace, across a growing number of trusts to safeguard systems and patient information, including prescription and blood type data.
In 2017, the WannaCry ransomware attack spread globally and implicated 61 NHS organisations. Since then, cyber security has been the subject of much debate and has remained firmly on the agenda of health policy experts and NHS Digital.
Darktrace Antigena successfully interrupted the attack across NHS organisations, driving the adoption of its autonomous response technology.
Craig York, Associate Director of IT at Milton Keynes University Hospital NHS Foundation Trust, said: “Autonomous response is the future for defending against fast-moving and unpredictable threats before they do damage. I am confident that we will be in a much better place to fend off another serious cyber-attack on the NHS with Darktrace at work. ”
Milton Keynes University Hospital NHS Foundation Trust, Royal Free London NHS Foundation Trust, Luton and Dunstable Hospital, and West Suffolk NHS Foundation Trust are just four NHS organisations enhancing their cybersecurity strategy with the Enterprise Immune System.
Dave Palmer, Director of Technology at Darktrace, said: “Today, cyber defenders have to react with the speed and accuracy of machines to keep our healthcare services and patients safe. ”
“As our hospitals and clinics become increasingly digitised and hyperconnected, it is reassuring to see more and more NHS organisations deploying Darktrace’s AI to catch sophisticated attacks, before they have the chance to cause a crisis. ”
Darktrace is sponsoring the Public Policy Projects NHS 70th Anniversary Reception taking place in London today, on the theme of ‘Developing a Digital Future’.